Global Microarray market- Trends, Forecast, and Growth Prospects Now Available from Technavio

Renewable energy

 

According to the latest market research study released by Technavio, the global microarray market is expected to grow at a CAGR of more than 14% during the forecast period 2016-2020.

This market research report by Technavio provides an in-depth analysis of the market in terms of revenue and emerging market trends. The report also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.

Click here to request a free sample of this report

Technavio research analysts categorize the global microarray market based on technology:

Global microarray market share by technology 2015

DNA microarray

34.29%

LOC

30,75%

Protein microarray

21.58%

Tissue microarray

11.01%

Other

2.37%

                                                                                                      Source: Technavio

The top three revenue contributing technology segments are discussed below:

DNA microarray

In 2015, DNA microarray segment accounted for a share of around 34% of the global microarray market. DNA microarray refers to a collection of microscopic DNA spots that are attached to a solid surface. It allows the simultaneous monitoring of expression of thousands of genes and can be used for determination of mRNA levels, as well as for genotyping. The tool is widely used to ascertain whether an individual’s DNA contains a mutation in genes.

The dominance of DNA microarray in the global microarray market is due to the adoption of DNA microarray technologies in applications such as gene expression and disease diagnosis. There is an increased usage of different types of DNA microarrays such as cDNA microarrays, oligonucleotide microarrays, bacterial artificial chromosome (BAC) microarrays, and SNP microarrays in gene expression. As these technologies, have the specificity factor and the capability to test thousands of genes simultaneously,” says Amber Chourasia, a senior analyst at Technavio for research on lab equipment.

DNA microarrays are used in medical diagnostics for the detection of genome abnormalities in many therapeutics areas such as cancer, infectious diseases, and cardiac disorders. The increase in the number of these cases has pulled the consumption of DNA microarray.

LOC

The LOC segment assimilates various laboratory functions on a single, small-sized chip that increases the operational efficiency of these solutions and saving money for end-users. LOC devices have an extensive range of applications in several sectors, including biotechnology, pharmaceuticals, and research. These solutions have been applied for disease diagnosis in the last few years for the rapid identification and differentiation of tropical pathogens. Tropical pathogens are the basis of illness among humans, especially in children, and are responsible for a high mortality rate across the globe. So, to curb this problem immense amount of research activity is being conducted globally to discover and develop solutions that will save lives. Recently, LOC devices have gained immense popularity owing to their capability to perform large laboratory operations on a small scale, saving a high percentage of floor space. Moreover, using LOC devices for lengthy and expensive laboratory processes can be conducted within a short span of time, as they require a small volume of samples and provide greater control over molecular concentrations and interactions.

Protein microarray

Protein microarray devices are used to examine the interactions and activities of several proteins simultaneously and help in monitoring the level of translation of proteins and the testing of enzyme actions.  Protein microarray has gained immense popularity as they are rapid, automated, and accurate in research and diagnostics. Typically, a protein microarray consists of a glass slide, bead, or microtiter plate, and nitrocellulose membrane. In the last few years, technological advances in protein microarrays have allowed end-users in disease diagnosis applications to investigate and deeply study indistinct protein profiles. These protein profiles are critical in disease identification that has increased their reliability and are used as biomarkers in disease treatment monitoring. Protein microarrays are classified into two categories that include analytical protein microarrays and functional protein microarrays. Analytical protein microarrays are usually antibody microarrays applied in multiplexed detection, while functional protein microarrays are used by researchers to study protein interaction and biochemical activity and assess immune responses.

Tissue microarray

Tissue microarray is developed by organizing small pieces of formalin-fixed tissue into an array in a single paraffin block. In disease diagnosis applications, tissue microarrays have a high potential for analyzing more than thousands of tumor samples on a single slide. They also allow analysis of proteins and genes that can provide important indications in cancer diagnosis. Tissue microarray has several applications in research such as the gene copy number determination, molecular profiling of tissue specimens, and hormone therapy investigation have increased their sales.

The top leading vendors operating in the global microarray market are:

  • Agilent Technologies
  • Illumina
  • Thermo Fisher Scientific
  • Merck

Other prominent vendors in the market include Applied Microarrays, Arrayit, AXO Science, BioCat, BioGenex, Biometrix Technology, Cepheid, GE Healthcare, InDevR, LC Sciences, Perkin Elmer, Phalanx Biotech, Qiagen, Takara Bio, and US Biomax.

A more detailed analysis is available in the Technavio report titled, ‘Global Microarray Market 2016-2020’. Technavio also customizes reports by other regions and specific segments upon request.

Other related reports:

To read more press releases- click here.

For any assistance or query, please contact our media team at:

media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com